With years of technical expertise and a platform that pushes your projects further, your progress is our priority.
Exclusive biosimilar licensing opportunities and AAV kits for gene therapy applications.
We are a global CDMO dedicated to impacting the global healthcare landscape by bringing trusted and affordable medicines to market, quickly.
Committed to innovation, we have revolutionized biologics production with our patented and validated continuous bioprocess manufacturing platform, EnzeneX™, that enables us to significantly reduce the cost of producing complex biologics and monoclonal antibodies (mAbs).
Our fully-integrated services and productive pipeline of biosimilars are designed to cater to your project’s every need.
An emerging biotech approached Enzene Biosciences with a novel Fully Human Albumin Binding (FHAB) protein, which suffered from low titers, poor viability after 10 days of growth, proteolytic clipping, limited operational pH range, and host cell protein (HCP) problems. Find out how we helped them achieve success.
Fueled by our continuous innovation and armed with EnzeneX™, our fully-integrated CDMO solutions and our biosimilars pipeline are designed to help bring your biologics innovations to life.